Cargando…
Clinical Utility of Lefamulin: If Not Now, When?
PURPOSE OF REVIEW: The looming threat of antimicrobial resistance requires robust stewardship and new developments in infectious diseases pharmacotherapy. This review discusses the pertinent spectrum and clinical data of lefamulin (Xenleta®), with a focus on potential real-world use. RECENT FINDINGS...
Autores principales: | Mercuro, Nicholas J., Veve, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344045/ https://www.ncbi.nlm.nih.gov/pubmed/32834786 http://dx.doi.org/10.1007/s11908-020-00732-z |
Ejemplares similares
-
Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy
por: Mahoney, Monica V., et al.
Publicado: (2021) -
Challenges of Antimicrobial Resistance and Stewardship in Solid Organ Transplant Patients
por: So, Miranda, et al.
Publicado: (2022) -
Antifungal Resistance and the Role of New Therapeutic Agents
por: Logan, Ashley, et al.
Publicado: (2022) -
Carbapenem-Resistant Enterobacterales: Considerations for Treatment in the Era of New Antimicrobials and Evolving Enzymology
por: Lasko, Maxwell J., et al.
Publicado: (2020) -
Evidence Regarding Rapid Initiation of Antiretroviral Therapy in Patients Living with HIV
por: Michienzi, Sarah M., et al.
Publicado: (2021)